April 12th, 2025
This conference has already taken place.
Description
Unlock the secrets to high-quality endoscopy at the Annual Advanced Therapeutic Endoscopy Symposium! Individual endoscopists will gain crucial insights into practice indicators and learn how to measure and enhance their performance effectively. Endoscopy unit directors and practice managers will discover practical strategies to implement these principles and elevate their practice standards.
We'll spotlight POEM (Peroral Endoscopic Myotomy) as a cutting-edge solution for esophageal dysmotility, providing essential guidance on patient referrals and practice establishment. Join us at Ohio State to bridge the gap in performance and embrace these innovative procedures.
For pricing information, see pricing tab below.
Dates and Times
Start: 4/12/2025 8:00 AM
End: 4/12/2025 2:30 PM
Objectives
1. Explain the association between high-quality endoscopy and patient outcomes.
2. Describe ways to utilize AI in endoscopy.
3. Describe best practices for difficult stone management in the bile duct and pancreatic duct.
4. Describe the safety and efficacy of endoscopic management of submucosal lesions.
5. Identify the potential clinical scenarios for consideration of 3rd space endoscopy and POEM.
6. Identify best practices for learning and implementing new procedures.
Agenda
.png)
.png)
Pricing
| Tier | Price |
|---|---|
| Free | $0.00 |
Speakers
Location
Fawcett Center
2400 Olentangy River Rd.
Columbus, OH 43202
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
Among all the planners, speakers, and reviewers for this educational activity only Dr. Peter Stanich, has a relevant financial relationship with a commercial interest (defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients), that relates to the content that will be discussed in this educational activity. All other speakers, faculty, planners, the reviewer and the CME provider have no relevant financial relationships to disclose.
| Speaker | Company | Relationship |
|---|---|---|
| Dr. Peter Stanich | ||
| Pfizer | Researcher | |
| Gaurdant | Researcher | |
| Freenome | Researcher | |